VISTAGEN THERAPEUTICS, INC. Prepaid Expense and Other Assets, Current
VISTAGEN THERAPEUTICS, INC. (VTGN) had Prepaid Expense and Other Assets, Current of $2.58 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Notes
us-gaap:PrepaidExpenseAndOtherAssetsCurrent · last filed 2026-08-14
- 2026-06-30: Prepaid Expense and Other Assets, Current $2.58M.
- 2026-03-31: Prepaid Expense and Other Assets, Current $1.54M.
- 2025-12-31: Prepaid Expense and Other Assets, Current $1.48M.
- 2025-09-30: Prepaid Expense and Other Assets, Current $1.76M.
| Period end | Prepaid Expense and Other Assets, Current | Prepaid Expense and Other Assets, Current as first filed |
|---|---|---|
| 2026-06-30 | $2.58M 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $1.54M 10-Q · filed 2026-08-14 | |
| 2025-12-31 | $1.48M 10-Q · filed 2026-02-12 | |
| 2025-09-30 | $1.76M 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $3.54M 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $1.59M 10-K · filed 2026-06-15 | |
| 2024-12-31 | $1.38M 10-Q · filed 2025-02-13 | |
| 2024-09-30 | $2.37M 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $2.47M 10-Q · filed 2024-08-13 | |
| 2024-03-31 | $1.51M 10-K · filed 2025-06-17 | $1.43M 10-K · filed 2024-06-11 |
| 2023-12-31 | $1.48M 10-Q · filed 2024-02-13 | |
| 2023-09-30 | $1.39M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $1.89M 10-Q · filed 2023-08-10 | |
| 2023-03-31 | $802.00K 10-K · filed 2024-06-11 | $802.70K 10-K · filed 2023-06-28 |
| 2022-12-31 | $953.20K 10-Q · filed 2023-02-07 | |
| 2022-09-30 | $1.56M 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $2.89M 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $2.75M 10-K · filed 2023-06-28 | |
| 2021-12-31 | $2.94M 10-Q · filed 2022-02-10 | |
| 2021-09-30 | $2.68M 10-Q · filed 2021-11-10 | |
| 2021-06-30 | $1.87M 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $875.70K 10-K · filed 2022-06-23 | $835.10K 10-K · filed 2021-06-29 |
| 2020-12-31 | $547.50K 10-Q · filed 2021-02-11 | |
| 2020-09-30 | $455.70K 10-Q · filed 2020-11-12 | |
| 2020-06-30 | $633.00K 10-Q · filed 2020-08-13 | |
| 2020-03-31 | $225.10K 10-K · filed 2021-06-29 | |
| 2019-12-31 | $319.00K 10-Q · filed 2020-02-13 | |
| 2019-09-30 | $604.50K 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $482.60K 10-Q · filed 2019-08-13 | |
| 2019-03-31 | $228.60K 10-K · filed 2020-06-29 | $250.90K 10-K · filed 2019-06-25 |
| 2018-12-31 | $853.80K 10-Q · filed 2019-02-12 | |
| 2018-09-30 | $648.00K 10-Q · filed 2018-10-29 | |
| 2018-06-30 | $617.30K 10-Q · filed 2018-08-14 | |
| 2018-03-31 | $644.80K 10-K · filed 2019-06-25 | |
| 2017-12-31 | $940.40K 10-Q · filed 2018-02-12 | |
| 2017-09-30 | $563.30K 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $498.00K 10-Q · filed 2017-08-14 | |
| 2017-03-31 | $456.60K 10-K · filed 2018-06-26 | |
| 2016-12-31 | $146.40K 10-Q · filed 2017-02-13 | |
| 2016-09-30 | $648.90K 10-Q · filed 2016-11-14 | |
| 2016-06-30 | $134.70K 10-Q · filed 2016-08-12 | |
| 2016-03-31 | $426.80K 10-K · filed 2017-06-29 | |
| 2015-12-31 | $728.30K 10-Q · filed 2016-02-16 | |
| 2015-09-30 | $1.10M 10-Q · filed 2015-11-16 | |
| 2015-06-30 | $1.47M 10-Q · filed 2015-08-14 | |
| 2015-03-31 | $35.70K 10-K · filed 2016-06-24 | |
| 2014-12-31 | $62.30K 10-Q · filed 2015-02-17 | |
| 2014-09-30 | $189.90K 10-Q · filed 2014-11-19 | |
| 2014-06-30 | $153.90K 10-Q · filed 2014-08-12 | |
| 2014-03-31 | $40.50K 10-K · filed 2015-06-29 | |
| 2013-12-31 | $40.50K 10-Q · filed 2015-02-17 | $70.60K 10-Q · filed 2014-02-14 |
| 2013-09-30 | $40.50K 10-Q · filed 2014-11-19 | $147.50K 10-Q · filed 2013-11-14 |
| 2013-06-30 | $40.50K 10-Q · filed 2014-08-12 | $134.90K 10-Q · filed 2013-08-14 |
| 2012-12-31 | $82.80K 10-Q · filed 2013-02-14 | |
| 2012-09-30 | $315.00K 10-Q · filed 2012-11-14 | |
| 2012-06-30 | $511.20K 10-Q · filed 2012-08-14 | |
| 2012-03-31 | $33.70K 10-K · filed 2014-06-25 | $50.90K 10-Q · filed 2012-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B |